Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 5
2018 40
2019 63
2020 79
2021 78
2022 44
2023 50
2024 62

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Results by year

Filters applied: . Clear all
Page 1
Kernel-based testing for single-cell differential analysis.
Ozier-Lafontaine A, Fourneaux C, Durif G, Arsenteva P, Vallot C, Gandrillon O, Gonin-Giraud S, Michel B, Picard F. Ozier-Lafontaine A, et al. Genome Biol. 2024 May 3;25(1):114. doi: 10.1186/s13059-024-03255-1. Genome Biol. 2024. PMID: 38702740 Free PMC article.
Sepsis-trained macrophages promote antitumoral tissue-resident T cells.
Broquet A, Gourain V, Goronflot T, Le Mabecque V, Sinha D, Ashayeripanah M, Jacqueline C, Martin P, Davieau M, Boutin L, Poulain C, Martin FP, Fourgeux C, Petrier M, Cannevet M, Leclercq T, Guillonneau M, Chaumette T, Laurent T, Harly C, Scotet E, Legentil L, Ferrières V, Corgnac S, Mami-Chouaib F, Mosnier JF, Mauduit N, McWilliam HEG, Villadangos JA, Gourraud PA, Asehnoune K, Poschmann J, Roquilly A. Broquet A, et al. Nat Immunol. 2024 May;25(5):802-819. doi: 10.1038/s41590-024-01819-8. Epub 2024 Apr 29. Nat Immunol. 2024. PMID: 38684922
VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance.
Pichol-Thievend C, Anezo O, Pettiwala AM, Bourmeau G, Montagne R, Lyne AM, Guichet PO, Deshors P, Ballestín A, Blanchard B, Reveilles J, Ravi VM, Joseph K, Heiland DH, Julien B, Leboucher S, Besse L, Legoix P, Dingli F, Liva S, Loew D, Giani E, Ribecco V, Furumaya C, Marcos-Kovandzic L, Masliantsev K, Daubon T, Wang L, Diaz AA, Schnell O, Beck J, Servant N, Karayan-Tapon L, Cavalli FMG, Seano G. Pichol-Thievend C, et al. Nat Commun. 2024 Apr 29;15(1):3602. doi: 10.1038/s41467-024-47985-z. Nat Commun. 2024. PMID: 38684700 Free PMC article.
Clathrin assemblies at a glance.
Vassilopoulos S, Montagnac G. Vassilopoulos S, et al. J Cell Sci. 2024 Apr 15;137(8):jcs261674. doi: 10.1242/jcs.261674. Epub 2024 Apr 24. J Cell Sci. 2024. PMID: 38668719 Review.
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study).
Nguyen-Khac F, Baron M, Guièze R, Feugier P, Fayault A, Raynaud S, Troussard X, Droin N, Damm F, Smagghe L, Susin S, Leblond V, Dartigeas C, Van den Neste E, Leprêtre S, Bernard OA, Roos-Weil D; on behalf the FILO (French Innovative Leukaemia Organization) Group. Nguyen-Khac F, et al. Br J Haematol. 2024 Apr 23. doi: 10.1111/bjh.19459. Online ahead of print. Br J Haematol. 2024. PMID: 38654616
UBAP2L ensures homeostasis of nuclear pore complexes at the intact nuclear envelope.
Liao Y, Andronov L, Liu X, Lin J, Guerber L, Lu L, Agote-Arán A, Pangou E, Ran L, Kleiss C, Qu M, Schmucker S, Cirillo L, Zhang Z, Riveline D, Gotta M, Klaholz BP, Sumara I. Liao Y, et al. J Cell Biol. 2024 Jul 1;223(7):e202310006. doi: 10.1083/jcb.202310006. Epub 2024 Apr 23. J Cell Biol. 2024. PMID: 38652117 Free PMC article.
Malignant features of minipig melanomas prior to spontaneous regression.
Débare H, Blanc F, Piton G, Leplat JJ, Vincent-Naulleau S, Rivière J, Vilotte M, Marthey S, Lecardonnel J, Coville JL, Estellé J, Rau A, Bourneuf E, Egidy G. Débare H, et al. Sci Rep. 2024 Apr 22;14(1):9240. doi: 10.1038/s41598-024-59741-w. Sci Rep. 2024. PMID: 38649394 Free PMC article.
The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial.
Lambaudie E, Bogart E, Le Deley MC, El Hajj H, Gauthier T, Hebert T, Collinet P, Classe JM, Lecuru F, Motton S, Conri V, Ferrer C, Marchal F, Ferron G, Probst A, Jauffret C, Narducci F. Lambaudie E, et al. Ann Surg Oncol. 2024 Apr 15. doi: 10.1245/s10434-024-15265-1. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38616209
377 results